Green Light Therapy for Chronic Pain

Recruiting in Palo Alto (17 mi)

Overseen byMohab M Ibrahim, PhD., MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Arizona

Trial Summary

What is the purpose of this trial?

This trial uses green light exposure to help reduce pain in patients with fibromyalgia and migraines. The green light likely works by decreasing brain inflammation and altering pain signals. Green light exposure has been shown to reduce headache days and improve quality of life in migraine patients without adverse events.

Research Team

Mohab M Ibrahim, PhD., MD

Principal Investigator

University of Arizona

Eligibility Criteria

This trial is for adults over 18 who speak English, have been diagnosed with fibromyalgia according to specific criteria, and experience chronic pain rated at least 5 out of 10 despite medical treatment. People with serious mental illness, color blindness, uncorrected cataracts or those paid for their condition are excluded.

Inclusion Criteria

My average pain level is 5 or more out of 10, and medications haven't helped.

My average pain level is 5 or more out of 10, and treatments haven't helped.

I have been diagnosed with fibromyalgia according to the latest criteria.

See 2 more

Exclusion Criteria

You are getting paid for your medical condition.

You have a history of color blindness or have not had your cataracts corrected.

You have a serious mental illness that causes you to have trouble telling what's real and what's not, or may lead to unusual behaviors.

See 1 more

Treatment Details

Interventions

Green Light (Light Therapy)

Trial OverviewThe study tests Green Light Therapy (GLED) as a potential treatment for fibromyalgia and chronic pain. It aims to understand how GLED might reduce pain by affecting the brain's processing of pain signals. Participants will be randomly assigned to receive either GLED or a placebo in a controlled environment.

Participant Groups

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Green light-emitting diode (GLED)Experimental Treatment1 Intervention

Subjects randomized to this arm will be exposed to GLED 2 hours a day for 10 weeks

Group II: White light-emitting diode (WLED)Placebo Group1 Intervention

Subjects randomized to this arm will be exposed to WLED 2 hours a day for 10 weeks